Long-Term Outcomes in Patients with Advanced Urothelial Carcinoma (Uc) Who Received Avelumab First-Line (1L) Maintenance with or Without Second-Line (2L) Treatment: Exploratory Analyses from Javelin Bladder 100.

AuthID
P-00X-EAF
10
Author(s)
Bellmunt, J
·
Duran, MAC
·
Sridhar, SS
·
Gurney, H
·
Costa, N
·
Di Pietro, A
·
Huang, B
·
Gupta, S
·
Grivas, P
Tipo de Documento
Abstract
Year published
2022
Publicado
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 40, Número: 16
Indexing
Publication Identifiers
Wos: WOS:000863680301380
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.